Nucleic Acid Labeling Market

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Report
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 30)
    4.1 Global Market Overview

5 Market Overview (Page No. - 33)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Product
           5.2.2 By Labeling Techniques
           5.2.3 By Application
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing Healthcare Expenditure
                    5.3.1.2 Low Cost of Genome Sequencing Leads to Increased Genomics Research
                    5.3.1.3 Applications in Disease Diagnosis
                    5.3.1.4 Increase in R&D Spending
           5.3.2 Restraints
                    5.3.2.1 Lack of Skilled Professionals in Transcriptomics
           5.3.3 Opportunities
                    5.3.3.1 Rising Opportunities in Emerging Markets
           5.3.4 Trends
                    5.3.4.1 Utilization of Low-To-Medium-Throughput Technologies

6 Nucleic Acid Labeling Market, By Products (Page No. - 42)
    6.1 Introduction
    6.2 Reagents & Kits
           6.2.1 Labels
                    6.2.1.1 Radioactive Labels
                    6.2.1.2 Non-Radioactive Labels
           6.2.2 Probes
                    6.2.2.1 Radioactive Probes
                    6.2.2.2 Non-Radioactive
    6.3 Services

7 Nucleic Acid Labeling Market, By Labeling Technique (Page No. - 55)
    7.1 Introduction
    7.2 PCR
    7.3 Nick Translation
    7.4 Random Primer
    7.5 In Vitro Transcription
    7.6 Reverse Transcription
    7.7 End Labeling

8 Nucleic Acid Labeling Market, By Application (Page No. - 69)
    8.1 Introduction
    8.2 DNA Sequencing
    8.3 Polymerase Chain Reaction
    8.4 Fluorescence in Situ Hybridization (FISH)
    8.5 Microarrays
    8.6 Blotting
    8.7 in Situ Hybridization
    8.8 Other Applications

9 Nucleic Acid Labeling Market, By Region (Page No. - 84)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
    9.4 Asia
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 117)
     10.1 Introduction
     10.2 Strategic Overview
     10.3 Market Share Analysis
     10.4 Competitive Situation and Trends
             10.4.1 New Product Launches & Product Upgrades
             10.4.2 Acquisitions
             10.4.3 Agreements
             10.4.4 Expansions
             10.4.5 Patents

11 Company Profiles (Page No. - 123)
     11.1 Introduction
     11.2 Agilent Technologies, Inc.
             11.2.1 Business Overview
             11.2.2 Products Offered
             11.2.3 Recent Developments
             11.2.4 MnM View
                        11.2.4.1 Financial Analysis
                        11.2.4.2 Strategic Analysis
     11.3 Enzo Biochem, Inc.
             11.3.1 Business Overview
             11.3.2 Products Offered
             11.3.3 Recent Development
             11.3.4 MnM View
                        11.3.4.1 Financial Analysis
                        11.3.4.2 Strategic Analysis
     11.4 F. Hoffman-La Roche AG
             11.4.1 Business Overview
             11.4.2 Products Offered
             11.4.3 Recent Development
             11.4.4 MnM View
                        11.4.4.1 Financial Analysis
                        11.4.4.2 Strategic Analysis
     11.5 General Electric Company
             11.5.1 Business Overview
             11.5.2 Products Offered
             11.5.3 Recent Developments
             11.5.4 MnM View
                        11.5.4.1 Financial Analysis
                        11.5.4.2 Strategic Analysis
     11.6 Merck KGaA (Germany)
             11.6.1 Business Overview
             11.6.2 Products Offered
             11.6.3 Recent Developments
             11.6.4 MnM View
                        11.6.4.1 Financial Analysis
                        11.6.4.2 Strategic Analysis
     11.7 New England Biolabs
             11.7.1 Business Overview
             11.7.2 Products Offered
             11.7.3 Recent Developments
             11.7.4 MnM View
                        11.7.4.1 Strategic Analysis
     11.8 Perkinelmer, Inc.
             11.8.1 Business Overview
             11.8.2 Products & Services Offered
             11.8.3 Recent Development
             11.8.4 MnM View
                        11.8.4.1 Financial Analysis
                        11.8.4.2 Strategic Analysis
     11.9 Promega Corporation
             11.9.1 Business Overview
             11.9.2 Products Offered
             11.9.3 Recent Developments
             11.9.4 MnM View
                        11.9.4.1 Strategic Analysis
     11.10 Thermo Fisher Scientific, Inc.
             11.10.1 Business Overview
             11.10.2 Products & Services Offered
             11.10.3 Recent Developments
             11.10.4 MnM View
                        11.10.4.1 Financial Analysis
                        11.10.4.2 Strategic Analysis
     11.11 Vector Laboratories
             11.11.1 Business Overview
             11.11.2 Products Offered
             11.11.3 Recent Developments
             11.11.4 MnM View
                        11.11.4.1 Strategic Analysis

12 Appendix (Page No. - 153)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports

List of Tables (77 Tables)

Table 1 Market Summary
Table 2 Increasing Healthcare Expenditure and Genomics Research Propelling the Growth of the Market
Table 3 High Consolidation, Competition in Market Restraining Its Growth
Table 4 Emerging Economies Present Significant Growth Opportunities
Table 5 Utilization of Low-To-Medium-Throughput Technologies is an Important Trend
Table 6 Market Size, By Product, 2013–2020 (USD Million)
Table 7 Market Size for Reagents & Kits, By Type, 2013–2020 (USD Million)
Table 8 Market Size for Reagents & Kits, By Region, 2013–2020 (USD Million)
Table 9 North America: Market Size for Reagents & Kits, By Region, 2013–2020 (USD Million)
Table 10 Market Size for Labels, By Region, 2013–2020 (USD Million)
Table 11 North America: Market Size for Labels, By Region, 2013-2020 (USD Million)
Table 12 Market Size for Non-Radioactive Labels, By Type, 2013–2020 (USD Million)
Table 13 Market Size for Probes, By Region, 2013–2020 (USD Million)
Table 14 North America: Market Size for Probes, By Region, 2013–2020 (USD Million)
Table 15 Market Size for Services, By Region, 2013–2020 (USD Million)
Table 16 North America: Market Size for Services, By Region, 2013–2020 (USD Million)
Table 17 Market Size, By Labeling Technique, 2013–2020 (USD Million)
Table 18 Market Size for PCR, By Region, 2013–2020 (USD Million)
Table 19 North America: Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 20 Market Size for Nick Translation, By Region, 2013–2020 (USD Million)
Table 21 North America: Market Size for Nick Translation, By Country, 2013–2020 (USD Million)
Table 22 Market Size for Random Primer Labeling, By Region, 2013–2020 (USD Million)
Table 23 North America: Nucleic Acid Labeling Market Size for Random Primer Labeling, By Country, 2013–2020 (USD Million)
Table 24 Market Size for in Vitro Transcription, By Region, 2013–2020 (USD Million)
Table 25 North America: Market Size for in Vitro Transcription, By Country, 2013–2020 (USD Million)
Table 26 Market Size for Reverse Transcription, By Region, 2013–2020 (USD Million)
Table 27 North America: Market Size for Reverse Transcription, By Country, 2013–2020 (USD Million)
Table 28 Market Size for End Labeling, By Region, 2013–2020 (USD Million)
Table 29 North America: Market Size for End Labeling, By Country, 2013–2020 (USD Million)
Table 30 Market Size, By Application, 2013–2020 (USD Million)
Table 31 Market Size for DNA Sequencing, By Region, 2013–2020 (USD Million)
Table 32 North America: Market Size for DNA Sequencing, By Region, 2013–2020 (USD Million)
Table 33 Market Size for PCR, By Region, 2013–2020 (USD Million)
Table 34 North America: Market Size for PCR, By Region, 2013–2020 (USD Million)
Table 35 Market Size for FISH, By Region, 2013–2020 (USD Million)
Table 36 North America: Market Size for FISH, By Region, 2013–2020 (USD Million)
Table 37 Market Size for Microarrays, By Region, 2013–2020 (USD Million)
Table 38 North America: Market for Microarrays, By Region, 2013–2020 (USD Million)
Table 39 Market Size for Blotting, By Region, 2013–2020 (USD Million)
Table 40 North America: Market Size for Blotting, By Region, 2013–2020 (USD Million)
Table 41 Market Size for in Situ Hybridization, By Region, 2013–2020 (USD Million)
Table 42 North America: Market Size for in Situ Hybridization, By Region, 2013–2020 (USD Million)
Table 43 Market Size for Other Applications, By Region, 2013–2020 (USD Million)
Table 44 North America: Market Size for Other Applications, By Region, 2013–2020 (USD Million)
Table 45 Market Size, By Region, 2013–2020 (USD Million)
Table 46 North America: Market Size, By Region, 2013–2020 (USD Million)
Table 47 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 48 North America: Market Size, By Reagents and Kits, 2013–2020 (USD Million)
Table 49 North America: Market Size, By Labeling Technique, 2013–2020 (USD Million)
Table 50 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 51 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 52 U.S.: Market Size, By Reagents and Kits, 2013–2020 (USD Million)
Table 53 U.S.: Market Size, By Labeling Technique, 2013–2020 (USD Million)
Table 54 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 55 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 56 Canada: Market Size, By Reagents and Kits, 2013–2020 (USD Million)
Table 57 Canada: Market Size, By Labeling Technique, 2013–2020 (USD Million)
Table 58 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 59 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 60 Europe: Market Size, By Reagents and Kits, 2013–2020 (USD Million)
Table 61 Europe: Market Size, By Labeling Technique, 2013–2020 (USD Million)
Table 62 Europe: Market Size, By Application, 2013–2020 (USD Million)
Table 63 Asia: Market Size, By Product, 2013–2020 (USD Million)
Table 64 Asia: Market Size, By Reagents and Kits, 2013–2020 (USD Million)
Table 65 Asia: Market Size, By Labeling Technique, 2013–2020 (USD Million)
Table 66 Asia: Market Size, By Application, 2013–2020 (USD Million)
Table 67 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 68 RoW: Market Size, By Reagents and Kits, 2013–2020 (USD Million)
Table 69 RoW: Market Size, By Labeling Technique, 2013–2020 (USD Million)
Table 70 RoW: Market Size, By Application, 2013–2020 (USD Million)
Table 71 Market Share Analysis, By Key Player, 2015
Table 72 Market Developments Between January 2013 and August 2015
Table 73 New Product Launches & Product Upgrades , 2013–2015
Table 74 Acquisitions, 2013–2015
Table 75 Agreements , 2013–2015
Table 76 Expansions, 2013–2015
Table 77 Patents, 2013–2015

List of Figures (89 Figures)

Figure 1 Nucleic Acid Labeling Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Market Size, By Product, 2015 vs 2020 (USD Million)
Figure 8 Market Size, By Labeling Technique, 2015 vs 2020 (USD Million)
Figure 9 Market Size, By Application, 2015 vs 2020 (USD Million)
Figure 10 Geographical Snapshot of the Nucleic Acid Labeling Market in 2015
Figure 11 Market Size, By Region, 2015 vs 2020 (USD Million)
Figure 12 Increasing Healthecare Expenditure to Drive Market Growth
Figure 13 Geographic Analysis: Nucleic Acid Labeling Market, By Application, 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period (2015 to 2020)
Figure 15 Market: By Product
Figure 16 Market: By Labeling Techniques
Figure 17 Market: By Application
Figure 18 Increasing Healthcare Expenditure Will Drive the Nucleic Acid Labeling Market
Figure 19 Increasing Healthcare Expenditure is the Most Important Driver for Nucleic Acid Labeling Market
Figure 20 Increasing R&D Spending Boosting the Growth of the Nucleic Acid Labeling Market
Figure 21 Nucleic Acid Labeling Market, By Product
Figure 22 Reagents & Kits Segment to Command the Largest Share of the Nucleic Acid Labeling Market in 2015
Figure 23 Labels to Command the Largest Share of the Nucleic Acid Labeling Reagents & Kits Market in 2015
Figure 24 North America Will Be the Largest Regional Segment of the Reagents & Kits Market in 2015
Figure 25 Asia to Be the Fastest-Growing Regional Segment of the Labels Market Between 2015 and 2020
Figure 26 Chemiluminescent Chemicals to Command the Largest Share of the Nucleic Acid Labeling Market for Non-Radioactive Labels in 2015
Figure 27 Asia to Be the Fastest-Growing Regional Segment of the Nucleic Acid Labeling Probes Market in the Forecast Period
Figure 28 North America Will Be the Largest Regional Segment of the Services Market in 2015
Figure 29 Nucleic Acid Labeling Market Segmentation, By Labeling Technique
Figure 30 PCR Segment to Dominate the Nucleic Acid Labeling Market in 2015
Figure 31 Asia to Witness Highest Growth in the Nucleic Acid Labeling Market for PCR
Figure 32 Asia is Expected to Be the Fastest-Growing Regional Segment for Nick Translation
Figure 33 North America to Dominate the Random Primer Market in 2015
Figure 34 In Vitro Transcription Market in Asia to Witness Highest Growth in the Forecast Period
Figure 35 Asia Will Be the Fastest-Growing Regional Segment for Reverse Transcription Between 2015 and 2020
Figure 36 End Labeling Segment to Witness Highest Growth in North America
Figure 37 Nucleic Acid Labeling Market, By Application
Figure 38 DNA Sequencing Segment Expected to Command the Largest Share of the Nucleic Acid Labeling Market in 2015
Figure 39 North America to Command the Largest Share of the DNA Sequencing Application Segment in 2015
Figure 40 North America to Dominate the Nucleic Acid Labeling Market for PCR in 2015
Figure 41 Asia to Grow at the Highest CAGR in the Forecast Period
Figure 42 North America to Dominate the Nucleic Acid Labeling Market for Microarrays in 2015
Figure 43 Asia to Be the Fastest-Growing Regional Segment in the Blotting Applications Market in 2015
Figure 44 Asia to Be the Fastest-Growing Regional Segment in the in Situ Hybridization Market in 2015
Figure 45 North America is Expected to Be the Largest Regional Market for Other Applications in 2015
Figure 46 Asia to Grow at the Highest Rate During the Forecast Period
Figure 47 Geographic Snapshot (2015)
Figure 48 North America: Macroindicators
Figure 49 North America: Market Snapshot
Figure 50 North American Geographic Snapshot (2015)
Figure 51 Reagents & Kits Expected to Hold the Largest Share of the North American Market, By Product, in 2015
Figure 52 Labels to Account for the Largest Share of the Nucleic Acid Labeling Reagents & Kits in Asia
Figure 53 PCR, the Dominant Labeling Technique Segment in 2015
Figure 54 DNA Sequencing to Be the Largest Application Segment of the North American Nucleic Acid Labeling Market in 2015
Figure 55 U.S.: Macroindicators
Figure 56 Reagents & Kits Expected to Hold Largest Share of U.S. Market, By Product, in 2015
Figure 57 Labels Estimated to Be the Largest Reagents & Kits Segment in the U.S. Nucleic Acid Labeling Market in 2015
Figure 58 PCR, the Dominant Labeling Technique Segment in 2015
Figure 59 DNA Sequencing to Be the Largest Application Segment of the U.S. Nucleic Acid Labeling Market in 2015
Figure 60 Canada: Macroindicators
Figure 61 Reagents & Kits Expected to Hold Largest Share of the Canadian Market, By Product, in 2015
Figure 62 Labels Estimated to Be the Largest Reagents & Kits Segment in the Canada Nucleic Acid Labeling Market in 2015
Figure 63 PCR, the Dominant Labeling Technique Segment in 2015
Figure 64 DNA Sequencing to Be the Largest Application Segment of the Canadian Nucleic Acid Labeling Market in 2015
Figure 65 Europe: Macroindicators
Figure 66 Reagents & Kits Expected to Hold Largest Share of the European Market, By Product, in 2015
Figure 67 Labels Estimated to Be the Largest Reagents & Kits Segment in the European Nucleic Acid Labeling Market in 2015
Figure 68 PCR, the Dominant Labeling Technique Segment in 2015
Figure 69 DNA Sequencing to Be the Largest Application Segment of the Europe Nucleic Acid Labeling Market in 2015
Figure 70 Asia: Macroindicators
Figure 71 Asia: Market Snapshot
Figure 72 Reagents & Kits Expected to Hold the Largest Share of the Asian Market, By Product, in 2015
Figure 73 Labels Estimated to Be the Largest Reagents & Kits Segment in the Asian Nucleic Acid Labeling Market in 2015
Figure 74 PCR, the Dominant Labeling Technique Segment in 2015
Figure 75 DNA Sequencing to Be the Largest Application Segment of the Asian Nucleic Acid Labeling Market in 2015
Figure 76 RoW: Macroindicators
Figure 77 Reagents & Kits Expected to Hold Largest Share of RoW Market, By Product, in 2015
Figure 78 Labels Estimated to Be the Largest Reagents & Kits Segment in the RoW Nucleic Acid Labeling Market in 2015
Figure 79 PCR, the Dominant Labeling Technique Segment in 2015
Figure 80 DNA Sequencing to Be the Largest Application Segment of the RoW Nucleic Acid Labeling Market in 2015
Figure 81 New Product Launch are the Key Strategy Adopted By Players in the Nucleic Acid Labeling Market, 2013–2015
Figure 82 Financial Performances of the Leading Market Players
Figure 83 Company Snapshot: Agilent Technologies, Inc.
Figure 84 Company Snapshot: Enzo Biochem, Inc.
Figure 85 Company Snapshot: F. Hoffman-La Roche AG
Figure 86 Company Snapshot: General Electric Company
Figure 87 Company Snapshot: Merck KGaA (Germany)
Figure 88 Company Snapshot: Perkinelmer, Inc.
Figure 89 Company Snapshot: Thermo Fisher Scientific, Inc.